11,634 results
Search Results
102. Forced swimming test in mice: a review of antidepressant activity
103. Evaluation of the mood and physical symptoms scale (MPSS) to assess cigarette withdrawal
104. Effects of modafinil on working memory processes in humans
105. Self-administration of fentanyl, cocaine and ketamine: effects on the pituitary–adrenal axis in rhesus monkeys
106. A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features
107. From molecular biology to pharmacogenetics: a review of the literature on antidepressant treatment and suggestions of possible candidate genes
108. Sigma receptors: biology and therapeutic potential
109. Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia
110. Pharmacological manipulation of human working memory
111. Pre-attentive processing and schizophrenia: animal studies
112. Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction
113. The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications
114. Corticosteroid-serotonin interactions in depression: a review of the human evidence
115. Alcohol intoxication increases allopregnanolone levels in male adolescent humans
116. Neuroleptic dysphoria: towards a new synthesis
117. Beyond the question of placebo controls: ethical issues in psychopharmacological drug studies
118. Psychopharmacological research ethics: special issues affecting US ethnic minorities
119. Ethical considerations in psychopharmacological research involving children and adolescents
120. Apparatus bias and place conditioning with ethanol in mice
121. Problem areas in the understanding of informed consent for research: study of middle-aged and older patients with psychotic disorders
122. Procedural learning in schizophrenia after 6 months of double-blind treatment with olanzapine, risperidone, and haloperidol
123. Continuing implications of the early evidence against the drive-reduction hypothesis of the behavioral effects of drugs
124. Behavioral pharmacology of buprenorphine, with a focus on preclinical models of reward and addiction
125. How does stress increase risk of drug abuse and relapse?
126. Pressure-sensitive and -insensitive coupling in γ-aminobutyric acida receptors
127. The effect of neuroleptic medication on prepulse inhibition in schizophrenia patients: current status and future issues
128. Agonist efficacy, drug dependence, and medications development: preclinical evaluation of opioid, dopaminergic, and GABAA-ergic ligands
129. Basic fibroblast growth factor as a mediator of the effects of glutamate in the development of long-lasting sensitization to stimulant drugs: studies in the rat
130. Alcohol-induced locomotor activation in C57BL/6J, A/J, and AXB/BXA recombinant inbred mice: strain distribution patterns and quantitative trait loci analysis
131. Effects of dopaminergic drugs on delayed reward as a measure of impulsive behavior in rats
132. Attenuation of specific PCP-evoked behaviors by the potent mGlu2/3 receptor agonist, LY379268 and comparison with the atypical antipsychotic, clozapine
133. Effect of central 5-hydroxytryptamine depletion on changeover behaviour in concurrent schedules of reinforcement
134. Psychopharmacology of conditioned reward: evidence for a rewarding signal at D1-like dopamine receptors
135. Neurobiological similarities in antidepressant sleep deprivation and psychostimulant use: a psychostimulant theory of antidepressant sleep deprivation
136. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation
137. Precipitating factors in spontaneous recurrence of methamphetamine psychosis
138. Benzodiazepine self-administration in humans and laboratory animals – implications for problems of long-term use and abuse
139. Effects of low and high doses of selective sigma ligands: further evidence suggesting the existence of different subtypes of sigma receptors
140. Dopamine ligands and the stimulus effects of amphetamine: animal models versus human laboratory data
141. Computer-administered clinical rating scales A review: A review
142. Polysomnographic effects of hypnotic drugs: A review
143. Sex differences in plasma cocaine levels and subjective effects after acute cocaine administration in human volunteers
144. Effects of the 5-HT1A receptor agonist flesinoxan in panic disorder
145. Effects of the putative dopamine D3 receptor agonist 7-OH-DPAT in rhesus monkeys trained to discriminate cocaine from saline
146. Randomized, double blind, controlled placebo-phase in trial of low dose phenelzine in the chronic fatigue syndrome
147. Ethological analysis of cholecystokinin (CCKA and CCKB) receptor ligands in the elevated plus-maze test of anxiety in mice
148. Effects of trepelennamine on brain monoamine turnover in morphine dependent and abstinent mice
149. Behavioural consequences of maternal exposure to natural cannabinoids in rats
150. Administration of antidepressants, diazepam and psychomotor stimulants further confirms the utility of Flinders Sensitive Line rats as an animal model of depression
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.